Valuation : Neuland Laboratories Limited

Market Cap 30TCr 316.08Cr 272.33Cr 257.86Cr 233.73Cr 438.49Cr 440.71Cr 3.06TCr 1.18TCr 15TCr 1.19TCr 1.16TCr 49TCr P/E 2027 *
63.2x
P/E 2028 * 48.4x
Enterprise Value 30TCr 318.76Cr 274.64Cr 260.05Cr 235.71Cr 442.21Cr 444.45Cr 3.09TCr 1.19TCr 15TCr 1.2TCr 1.17TCr 49TCr EV / Sales 2027 *
12.5x
EV / Sales 2028 * 10.4x
Free-Float
62.26%
Yield 2027 *
0.1%
Yield 2028 * 0.13%
1 day-1.11%
1 week+3.86%
Current month+2.28%
1 month+2.53%
3 months+38.66%
6 months+83.47%
Current year+55.09%
1 week 22,415
Extreme 22415
24,225
1 month 22,415
Extreme 22415
24,225
Current year 11,500
Extreme 11500
24,225
1 year 11,500
Extreme 11500
24,225
3 years 3,400
Extreme 3400
24,225
5 years 967
Extreme 967
24,225
10 years 245.75
Extreme 245.75
24,225
Manager TitleAgeSince
Chief Executive Officer 47 01/04/2026
Director of Finance/CFO - 23/11/2022
Chief Tech/Sci/R&D Officer - 01/03/2023
Director TitleAgeSince
Director/Board Member 50 01/01/2002
Chairman 82 07/01/1984
Director/Board Member 47 01/03/2007
Change 5-day change 1-year change 3-year change Capi.($)
-1.11%+3.86% - - 316.08Cr
-0.65%-2.93%+47.52%+87.34% 99TCr
-0.29%-3.51%+48.78%+63.27% 64TCr
+0.83%+0.26%+16.76%+72.52% 45TCr
-0.38%-3.59%+28.24%+35.57% 34TCr
-0.09%-13.54%+10.08%+26.87% 26TCr
-0.43%-2.48%-2.07%+11.48% 25TCr
-1.34%-13.70%+33.47%+44.18% 20TCr
-3.44%-7.51%-20.08%-59.58% 19TCr
-0.75%-4.82%+21.94%+86.55% 18TCr
Average -0.77%-5.76%+20.52%+40.91% 38.94TCr
Weighted average by Cap. -0.51%-4.42%+29.87%+55.71%

Financials

2027 *2028 *
Net sales 2.44TCr 26Cr 22Cr 21Cr 19Cr 35Cr 36Cr 247.82Cr 95Cr 1.24TCr 96Cr 94Cr 3.93TCr 2.93TCr 31Cr 26Cr 25Cr 23Cr 42Cr 43Cr 296.82Cr 114.14Cr 1.49TCr 115.05Cr 112.52Cr 4.7TCr
Net income 479.83Cr 5.02Cr 4.33Cr 4.1Cr 3.71Cr 6.97Cr 7Cr 49Cr 19Cr 244.12Cr 19Cr 18Cr 771.39Cr 626.47Cr 6.56Cr 5.65Cr 5.35Cr 4.85Cr 9.1Cr 9.14Cr 64Cr 24Cr 318.72Cr 25Cr 24Cr 1.01TCr
Net Debt 256.12Cr 2.68Cr 2.31Cr 2.19Cr 1.98Cr 3.72Cr 3.74Cr 26Cr 9.99Cr 130.3Cr 10Cr 9.85Cr 411.74Cr 98Cr 1.03Cr 88.33L 83.63L 75.8L 1.42Cr 1.43Cr 9.93Cr 3.82Cr 50Cr 3.85Cr 3.77Cr 157.44Cr
Logo Neuland Laboratories Limited
Neuland Laboratories Ltd. is a global provider of active pharmaceutical ingredients (APIs) contract development and manufacturing organization (CDMO) services. It is focused on manufacture and sale of active pharmaceutical ingredients and allied services. It supports biotechnology and pharmaceutical companies in the design, development and manufacturing of complex APIs. It has two business verticals: generic drug substances (GDS) and custom manufacturing solutions (CMS). It develops and manufactures non-exclusive APIs both Prime APIs comprising large volume, mature molecules, and specialty APIs comprising lower volume, complex molecules with less competition. It develops small molecules and peptides for clinical trials and beyond. It provides an end-to-end continuum of customized services from early-stage drug development (Pre-IND) through to commercial manufacturing of complex APIs, including process development, process optimization, analytical testing, and regulatory support.
Employees
2,183
Date Price Change Volume
11/26/11 ₹23,535.00 -1.11% 43,901
10/26/10 ₹23,800.00 +2.61% 55,257
09/26/09 ₹23,195.00 -3.33% 57,976
08/26/08 ₹23,995.00 +4.92% 82,211
07/26/07 ₹22,870.00 +0.93% 22,291
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
23,536.20INR
Average target price
24,334.75INR
Spread / Average Target
+3.39%

Quarterly revenue - Rate of surprise

40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!